Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung Cancer
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Estrogen signaling is critical in the progression of tumors that bear estrogen receptors. In most patients with breast cancer, inhibitors that block interactions of estrogen with its receptors or suppress the production of endogenous estrogens are important interventions in the clinic. Recent evidence now suggests that estrogen also contributes to the pathogenesis of non–small cell lung cancer (NSCLC). We used a human lung cancer xenograph model system to analyze the effect of aromatase or estradiol on tumor growth. We further examined the level of protein expression of aromatase in 422 patients with NSCLC using a high-density tissue microarray. Results were confirmed and validated on an independent patient cohort (n = 337). Lower levels of aromatase predicted a greater chance of survival in women 65 years and older. Within this population, the prognostic value of aromatase was greatest in earlier stage lung cancer (stage I/II). In addition, for women with no history of smoking, lower aromatase levels were a strong predictor of survival. Our findings implicate aromatase as an early-stage predictor of survival in some women with NSCLC. We predict that women whose lung cancers have higher levels of aromatase might be good candidates for targeted treatment with aromatase inhibitors. [Cancer Res 2007;67(21):10484–90]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
Davison, S. L., Bell, R., Donath, S., Montalto, J. G., & Davis, S. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0212 · Cited by 998
Vermeulen, A., Kaufman, J. M., Goemaere, S., & Van Pottelberg, I. (2002) · The Aging Male · doi:10.1080/tam.5.2.98.102 · Cited by 452 · cited 1×
“Of note, estrogen levels in men stay relatively constant with age (34).”
BackgroundBurger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6740 · Cited by 439
Determinants of Serum Total and Free Testosterone Levels in Women over the Age of 65 Years
Cappola, A. R., Ratcliffe, S. J., Bhasin, S., Blackman, M. R., Cauley, J., Robbins, J., Zmuda, J. M., Harris, T., & Fried, L. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1399 · Cited by 67
Cited by
The different roles of ER subtypes in cancer biology and therapy
Thomas, C., & Gustafsson, J.-Å. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3093 · Cited by 654
Sex differences and sex steroids in lung health and disease
Townsend, E. A., Miller, V. M., & Prakash, Y. S. (2012) · Endocrine Reviews · doi:10.1210/er.2010-0031 · Cited by 395
METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis
Meng, W., Xiao, H., Zhao, R., Chen, J., Wang, Y., Mei, P., Li, H., & Liao, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01194-9 · Cited by 16
Single-click, semi-automatic lung nodule contouring using hierarchical conditional random fields
Haider, S. A., Shafiee, M. J., Chung, A., Khalvati, F., Oikonomou, A., Wong, A., & Haider, M. A. (2015) · 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2015.7164073 · Cited by 6
“With 27% of cancer deaths attributed to lung cancer, it makes it the deadliest cancer for both genders [1]; however, if caught early enough, the 5-year survival rate for is 49% [2].”
Background
Metadata
- Authors
- Mah, V., Seligson, D. B., Li, A., Márquez, D. C., Wistuba, I. I., Elshimali, Y., Fishbein, M. C., Chia, D., Pietras, R. J., & Goodglick, L.
- Venue
- Cancer Research
- Published
- 2007-11-01
- Volume
- 67
- Issue
- 21
- Pages
- 10484-10490
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2122931235
- Cited by
- 136
- References
- 6
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-2607
- The paper
- Mah, V., Seligson, D. B., Li, A., Márquez, D. C., Wistuba, I. I., Elshimali, Y., Fishbein, M. C., Chia, D., Pietras, R. J., & Goodglick, L. (2007). Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-2607
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.